{"id":"https://openalex.org/W210223755","doi":"https://doi.org/10.4045/tidsskr.09.34296","title":"Irreversible, uselektive monoaminoksidasehemmere","display_name":"Irreversible, uselektive monoaminoksidasehemmere","alternate_titles":[],"publication_year":2009,"publication_date":"2009-04-16","ids":{"openalex":"https://openalex.org/W210223755","doi":"https://doi.org/10.4045/tidsskr.09.34296","mag":"210223755","pmid":"https://pubmed.ncbi.nlm.nih.gov/19373300"},"language":"no","primary_location":{"id":"doi:10.4045/tidsskr.09.34296","doi":"https://doi.org/10.4045/tidsskr.09.34296","is_oa":true,"landing_page_url":"https://doi.org/10.4045/tidsskr.09.34296","pdf_url":null,"source":{"id":"https://openalex.org/S4210239295","display_name":"Tidsskrift for Den norske legeforening","issn_l":"0029-2001","issn":["0029-2001","0807-7096"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["ddh","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310314069","host_organization_name":"Norwegian Medical Association","host_organization_lineage":["https://openalex.org/P4310314069"],"host_organization_lineage_names":["Norwegian Medical Association"],"type":"journal"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for Den norske legeforening","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W210223755"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.4045/tidsskr.09.34296","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015474937","display_name":"Ingrid Castberg","orcid":"https://orcid.org/0000-0003-1400-6545","observed_orcids":["https://orcid.org/0000-0003-1400-6545"]},"institutions":[{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid Castberg","raw_affiliation_strings":["Psykisk helsevern avdeling \u00d8stmarka, St. Olavs hospital, Postboks 3008 Lade, 7441 Trondheim. ingrid.castberg@stolav.no","Psykisk helsevern avdeling \u00d8stmarka, St. Olavs hospital, Postboks 3008 Lade, 7441 Trondheim"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psykisk helsevern avdeling \u00d8stmarka, St. Olavs hospital, Postboks 3008 Lade, 7441 Trondheim. ingrid.castberg@stolav.no","institution_ids":["https://openalex.org/I4210104358"]},{"raw_affiliation_string":"Psykisk helsevern avdeling \u00d8stmarka, St. Olavs hospital, Postboks 3008 Lade, 7441 Trondheim","institution_ids":["https://openalex.org/I4210104358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olav Spigset","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7902-9014","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"129","issue":"8","first_page":"746","last_page":"748"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9430000185966492},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9459999799728394},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9800000190734863},{"id":"https://openalex.org/keywords/prescribing-precautions","display_name":"prescribing precautions","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.6615310907363892},{"id":"https://openalex.org/C63428231","wikidata":"https://www.wikidata.org/wiki/Q9043","display_name":"Norwegian","level":2,"score":0.6581488847732544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5163348913192749},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4715690016746521},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.4635905623435974},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.450148344039917},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33893173933029175},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.33240097761154175},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1812736690044403},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.08122724294662476},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.07058736681938171},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06099247932434082},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001628","descriptor_name":"Beverages","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007520","descriptor_name":"Isocarboxazid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010353","descriptor_name":"Patient Education as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010624","descriptor_name":"Phenelzine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014191","descriptor_name":"Tranylcypromine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020230","descriptor_name":"Serotonin Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4045/tidsskr.09.34296","doi":"https://doi.org/10.4045/tidsskr.09.34296","is_oa":true,"landing_page_url":"https://doi.org/10.4045/tidsskr.09.34296","pdf_url":null,"source":{"id":"https://openalex.org/S4210239295","display_name":"Tidsskrift for Den norske legeforening","issn_l":"0029-2001","issn":["0029-2001","0807-7096"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["ddh","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310314069","host_organization_name":"Norwegian Medical Association","host_organization_lineage":["https://openalex.org/P4310314069"],"host_organization_lineage_names":["Norwegian Medical Association"],"type":"journal"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for Den norske legeforening","raw_type":"journal-article"},{"id":"pmid:19373300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19373300","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","raw_type":"English Abstract"}],"best_oa_location":{"id":"doi:10.4045/tidsskr.09.34296","doi":"https://doi.org/10.4045/tidsskr.09.34296","is_oa":true,"landing_page_url":"https://doi.org/10.4045/tidsskr.09.34296","pdf_url":null,"source":{"id":"https://openalex.org/S4210239295","display_name":"Tidsskrift for Den norske legeforening","issn_l":"0029-2001","issn":["0029-2001","0807-7096"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["ddh","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310314069","host_organization_name":"Norwegian Medical Association","host_organization_lineage":["https://openalex.org/P4310314069"],"host_organization_lineage_names":["Norwegian Medical Association"],"type":"journal"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for Den norske legeforening","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W193065994","https://openalex.org/W203031526","https://openalex.org/W255240257","https://openalex.org/W1682768769","https://openalex.org/W1998408883","https://openalex.org/W2419393278","https://openalex.org/W2475875872"],"related_works":["https://openalex.org/W1866098728","https://openalex.org/W4312693134","https://openalex.org/W2043574482","https://openalex.org/W2401080563","https://openalex.org/W2574525728","https://openalex.org/W2410980602","https://openalex.org/W2048077192","https://openalex.org/W2984965789","https://openalex.org/W61714558","https://openalex.org/W4281681254"],"abstract_inverted_index":{"Irreversible,":[0],"non-selective":[1],"monoamine":[2],"oxidase":[3],"(MAO)":[4],"inhibitors":[5],"were":[6],"among":[7],"the":[8,42,56],"first":[9],"antidepressants.":[10],"No":[11],"drugs":[12],"in":[13,19],"this":[14],"group":[15],"are":[16],"currently":[17],"marketed":[18],"Norway,":[20],"but":[21],"many":[22],"physicians":[23],"will":[24],"see":[25],"patients":[26],"using":[27],"them,":[28],"as":[29],"they":[30],"can":[31],"be":[32],"prescribed":[33],"on":[34],"a":[35],"named":[36],"patient":[37],"basis":[38],"after":[39],"application":[40],"to":[41,55],"Norwegian":[43],"Medicines":[44],"Agency.":[45],"This":[46],"article":[47],"presents":[48],"adverse":[49],"effects,":[50],"interactions":[51],"and":[52],"precautions":[53],"related":[54],"use":[57],"of":[58],"these":[59],"drugs.":[60]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W210223755","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
